US7517685B2ExpiredUtilityPatentIndex 66
Gene promoters
Est. expiryDec 13, 2021(expired)· nominal 20-yr term from priority
C12Q 2600/158C12N 15/80C07K 14/37C12Q 1/6895C12N 15/1034C12Q 1/68C12N 15/10
66
PatentIndex Score
7
Cited by
11
References
11
Claims
Abstract
The invention is directed to a method for obtaining a promoter from an organism using a proteomics approach, isolated promoters from fungal species and uses of the isolated promoters.
Claims
exact text as granted — not AI-modified1. An isolated hex 1 promoter of Trichoderma reesei , having a nucleotide sequence substantially as shown in SEQ ID NO: 1, a nucleotide sequence which hybridizes to the nucleotide sequence as shown in SEQ ID NO: 1 under stringent conditions, or having a functional part of the sequence shown in SEQ ID NO: 1 which is capable of controlling expression of a gene when in a fungal species.
2. The hex1 promoter according to claim 1 having the nucleotide sequence substantially as shown in SEQ ID NO: 1.
3. The hex1 promoter according to claim 1 having a nucleotide sequence which hybridizes to the sequence of SEQ ID NO:1 under high stringency hybridization conditions.
4. A vector or transformed cell which contains the isolated hex1 promoter according to claim 1 .
5. The vector according to claim 4 selected from the group consisting of nucleic acid vector, plasmid, and viral vector.
6. A recombinant DNA construct comprising the isolated hex1 promoter according to claim 1 operably linked to a gene.
7. The DNA construct according to claim 6 wherein the gene encodes a protein.
8. The DNA construct according to claim 7 wherein the protein is selected from the group consisting of an hydrolytic enzyme, and molecule suitable for therapeutic or pharmaceutical use.
9. The DNA construct according to claim 8 wherein the hydrolytic enzyme is selected from the group consisting of phytases, cellulases, xylanases, beta-glucanases, amylases, lipases, and proteases.
10. The DNA construct according to claim 8 wherein the molecule suitable for therapeutic or pharmaceutical use is selected from the group consisting of proteins, antibodies, growth factors, growth inhibitors, and tissue activators.
11. An expression system containing the DNA construct according to claim 7 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.